Accelerating clinical studies is a mission that affects us all.
Our team recently returned from the most patient-centric conference we’ve ever attended: Medicine X. Hosted by Stanford Medicine, this year’s conference focused on the theme “Citizen.” Panels and talks centered around the impact we as citizens can make on health care outcomes for everyone.Read more
In our work connecting patients to trials, we’ve partnered with dozens of Alzheimer’s organizations to ensure that our search tool is available when and where patients are looking for information. For World Alzheimer’s Day, we asked a few of these organizations to weigh in on two key questions pertaining to Alzheimer’s research and the future of Alzheimer’s treatment. Thanks to our participants for your words of wisdom:Read more
Over the weekend, Antidote’s VP of Engineering, Dean Sellis, and our Entrepreneur-in-Residence, Ed Godber, attended a favorite innovation conference: the Royal Society of Medicine’s Medical Innovations Summit. They were thrilled with the diverse array of topics covered and the fascinating group of innovators who attended, and they were happy to share perspective on the current state of medical research, and what Antidote is doing to change it.Read more
Last week, we were honored to be Executive Sponsors at at the 7th Annual DPharm: Disruptive Innovations to Advance Clinical Trials conference in Boston. DPharm is a leading pharma conference that brings together innovators involved with clinical trials to share and discuss the latest ideas. Last week's event hosted more than 400 of the industry's most creative thinkers.Read more